Sean Kim
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
8
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRRX DURECT | Downgrades: Hold | n/a | $1.35 | - | 2 | Nov 9, 2023 | |
| ARQT Arcutis Biotherapeutics | Downgrades: Hold | n/a | $8.72 | - | 2 | Nov 8, 2023 | |
| CLSD Clearside Biomedical | Initiates: Buy | $6 | $1.03 | +482.52% | 1 | Jun 14, 2023 | |
| OVID Ovid Therapeutics | Initiates: Buy | $6 | $1.18 | +408.47% | 1 | Jun 14, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $26 | $11.70 | +122.22% | 1 | Jun 14, 2023 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $7 | $3.04 | +130.26% | 1 | Mar 14, 2023 |
DURECT
Nov 9, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.35
Upside: -
Arcutis Biotherapeutics
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $8.72
Upside: -
Clearside Biomedical
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $1.03
Upside: +482.52%
Ovid Therapeutics
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $1.18
Upside: +408.47%
EyePoint Pharmaceuticals
Jun 14, 2023
Initiates: Buy
Price Target: $26
Current: $11.70
Upside: +122.22%
Trevi Therapeutics
Mar 14, 2023
Initiates: Buy
Price Target: $7
Current: $3.04
Upside: +130.26%